Background: We sought to establish the long-term safety of drug-eluting stents compared
with bare-metal stents in a usual care setting. Methods: Using data from a prospective …

Background Recent reports suggest that off-label use of drug-eluting stents is associated
with an increased incidence of adverse events. Whether the use of bare-metal stents would …

Background Previous research suggests that the early benefit from revascularization with
drug-eluting stents might diminish over time. Methods We performed an extended analysis …

Background Limited data are available on the long-term effects of contemporary drug-eluting
stents versus contemporary bare-metal stents on rates of death, myocardial infarction, repeat …

The use of drug-eluting stents has become widespread globally. However, in the last 2 years
concerns have been raised regarding their long-term safety. 1, 2 Recent registry studies and …

Background The long-term safety and efficacy of drug-eluting coronary stents have been
questioned. Methods We evaluated 47,967 patients in Sweden who received a coronary …

Background Recent reports have indicated that there may be an increased risk of late stent
thrombosis with the use of drug-eluting stents, as compared with bare-metal stents. Methods …

Objectives: To ascertain the long‐term safety, efficacy, and pattern of use of drug‐eluting
stents (DES) in routine clinical practice. Methods: We analyzed a registry of 6,583 …

Background Several randomized trials have shown the effectiveness of drug-eluting stents
(DES) over bare metal stents (BMS) in terms of repeat revascularization at 1 year; however …

BACKGROUND: Long-term safety of drug-eluting stent (DES) is still a concern. We aimed to
assess the impact of DES use on all-cause mortality and target-lesion revascularisation …